Security
Windward Bio Group AG Common Shares · WWB
WWBNASDAQCommon stockCurrentCIK 2145089Updated Nov 19, 2026
WWB price & chart
Loading TradingView…
NASDAQ:WWB on TradingView ↗About the company
We are a clinical-stage biotechnology company developing ultra-long-acting antibody medicines for patients with serious respiratory and dermatologic diseases, including asthma, chronic obstructive pulmonary disease, or COPD, and atopic dermatitis. We estimate these diseases collectively represent a $60 billion peak market opportunity for biologic therapies, as we believe the majority of patients eligible to receive biologic treatment for these diseases remain untreated. Our product candidates can potentially address this significant unmet need, allow for treatment of a broader population of patients, improve efficacy, and improve dosing convenience and adherence to treatment. We estimate that these diseases collectively affect more than 100 million people in the United States, EU5 (France, Germany, Italy, Spain, and the United Kingdom), and Japan and more than 8 million are eligible for biologics treatment.
In the news
Recent filings
Show 5 more recent filings
Offerings
Registration 333-299608
- Gross proceeds
- 174999989.0
- Net proceeds
- 162749989.77
- Deal price
- 17.0
- Shares
- 10294117
- Offering price
- $17.00
- Ticker
- WWB
Underwriters: Jefferies LLC, TD Securities LLC, Piper Sandler & Co., UBS Securities LLC
Filing attachments
d111653dex107.htm · F-1/A · 2026-11-09
Exhibit 10.7 COMMON SHARE AND PRE-FUNDED WARRANT PURCHASE AGREEMENT T HIS C OMMON S HARE AND P RE -F UNDED W ARRANT P URCHASE A GREEMENT ( THIS “A GREEMENT ”) is entered into as of November 9, 2026 (the “Effective Date”), by and between Sanofi Foreign Participations B.V., a company incorporated under the laws of the Netherlands (the “Investor”) and Windward Bio Group AG, a Swiss corporation (Aktiengesellschaft) organized under the laws of Switzerland, with registered office in Basel, Switzerla…
Read attachment ↗d111653dex42.htm · F-1/A · 2026-11-09
Exhibit 4.2 FORM OF PRE-FUNDED WARRANT THE SECURITIES REPRESENTED BY THIS WARRANT AND THE SECURITIES ISSUABLE UPON ITS EXERCISE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THEY MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT OR AN AVAILABLE EXEMPTION FROM REGISTRATION. WINDWARD BIO GROUP AG PRE-FUNDED WARRANT TO PURCHASE COMMON SHARES Number of Warrant Shares: [•…
Read attachment ↗d111653dex41.htm · F-1 · 2026-10-23
Exhibit 4.1 Form of Series B Warrant Agreement dated as of [date] by and among Windward Bio Group AG (the Company) Aeschenplatz 6 4052 Basel Switzerland and [name] (the Warrant Holder) [address] (the Company and the Warrant Holder each a Party and together the Parties) Whereas 3 1. Definitions and Interpretation …
Read attachment ↗